Lead Plaintiff Deadline: October 23, 2018
Please Upload related files below
Fill in below.
Looking for more?
(i) CV Sciences’ Patent for CVSI-007, the Company’s leading drug candidate, had been rejected by the USPTO; (ii) accordingly, CV Sciences had significantly overstated the commercial viability of CVSI-007; and (iii) as a result, CV Sciences’ public statements were materially false and misleading at all relevant times.
In order to be included in the lawsuit, you must have incurred a loss on shares of purchased during the class period listed above.
If you suffered a loss in during the relevant time frame, you have until October 23, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.